Latest News

Tuesday, April 28, 2015 | Miscellaneous

Stealth BioTherapeutics Expands Ocuvia’s Clinical Development into Rare Mitochondrial Optic Neuropathies

Stealth BioTherapeutics, a clinical-stage biopharmaceutical company developing drug candidates for mitochondrial dysfunction, announced expansion of its ophthalmology program with FDA granting a Type …

Read the full story

Tuesday, April 28, 2015 | Product Releases

Sleep-Wake Disorder Drug Hetlioz Gets Nod in Europe

The European Medicines Agency (EMA) has recommended marketing authorization for tasimelteon (Hetlioz), a melatonin-receptor agonist, for the treatment of adults with a chronic circadian rhythm conditi…

Read the full story

Tuesday, April 28, 2015 | Clinical Trials

Extended-Release Dexamethasone Promising for Cataracts

Despite contradictory results from two phase 3 trials, the use of a sustained-release dexamethasone plug to treat inflammation related to cataract surgery is effective, researchers report. "…

Read the full story

Tuesday, April 28, 2015 | Management/Leadership, TxCell

TxCell Appoints Stéphane Boissel as Chief Executive Officer and Promotes Miguel Forte to Chief Operating Officer

TxCell SA announced the appointment of Stéphane Boissel as Chief Executive Officer. In addition, Dr. Miguel Forte, previously SVP Clinical and Regulatory, is promoted to Chief Operating Officer…

Read the full story

Monday, April 27, 2015 | Product Releases

First FDA Cleared Ophthalmic App for Monitoring AMD and DR

Vital Art and Science has introduced the mVT Service, a medical device and physician portal that tracks the progression of vision damaging diseases such as age-related macular degeneration and diabeti…

Read the full story

Monday, April 27, 2015 | Earnings & Financials, Acucela

Acucela Provides Company Updates

Acucela announced that it has made progress on the three strategic imperatives previously announced in its 2014 Annual Report to Shareholders to increase the value of the company and enhance sharehold…

Read the full story

Monday, April 27, 2015 | Medical Studies

Ripasudil Lowers Intraocular Pressure in Primary Open-Angle Glaucoma

Ripasudil lowers intraocular pressure (IOP) in patients with primary open-angle glaucoma who are already being treated with timolol or latanoprost, researchers from Japan report. Prostaglandins like l…

Read the full story

Monday, April 27, 2015 | Medical Studies

Simple Eye Test for 6-Year-Olds Predicts Need for Glasses in Teen Years

Researchers have found that a simple eye test in first grade could predict the onset of nearsightedness by eight grade. Such a test could enable parents to plan eye testing schedules and glasses, and …

Read the full story

Friday, April 24, 2015 | Grants/Awards

Sensimed AG Receives the International Press Prize During the International Exhibition of Inventions of Geneva

Sensimed AG announced that the company received the International Press Prize during the 43rd International Exhibition of Inventions of Geneva, according to a company news release. Sensime…

Read the full story

Friday, April 24, 2015 | Health Care

Most Ophthalmologists Think They Are Underpaid

Ophthalmologists are in the middle of the pack when it comes to compensation and professional satisfaction. Yet the majority of ophthalmologists think they should be better paid, according to the Meds…

Read the full story

Friday, April 24, 2015 | Product Releases

EyeNetra Launches Blink, an On-Demand, Mobile Vision Testing Service

Mobile health care is taking on a new dimension with the launch in New York City this week of Blink, an on-demand, in-home vision testing service that is the first of its kind. Developed by EyeNetra, …

Read the full story

Thursday, April 23, 2015 | Clinical Trials, Aerie Pharmaceuticals

Rhopressa Phase 3 Trial (Rocket 1) Misses Primary Endpoint

Aerie Pharmaceuticals reported that their phase 3 registration trial (Rocket 1) did not meet its primary efficacy endpoint of demonstrating non-inferiority of IOP lowering for once-daily Rhopressa com…

Read the full story

Thursday, April 23, 2015 | Clinical Trials, Dry Eye

Mitotech Announces Phase 2 Data Showing Positive Effect of SkQ1 in Patients with Dry Eye Syndrome

Mitotech SA announced that it has achieved significant positive results in its phase 2 clinical trial of SkQ1 compound in patients with moderate to severe dry eye syndrome, according to a company news…

Read the full story

Thursday, April 23, 2015 | Medical Studies

Treatment That Slows AMD Vision Loss With One Stem Cell Injection Shows Promise

There are currently no treatments that slow the progress of age-related macular degeneration - a major cause of vision loss in seniors resulting from a deterioration of the center of the retina. But n…

Read the full story

Wednesday, April 22, 2015 | Acquisitions/Mergers, Clearside Biomedical , iScience

Clearside Biomedical Announces Purchase of iScience Patent Portfolio for Suprachoroidal Space Drug Delivery

Clearside Biomedical announced the purchase and acquisition of iScience Interventional Corporation’s patent portfolio, covering drug delivery to the suprachoroidal space (SCS), according t…

Read the full story
Load More